Refresh

Aurobindo Pharma Ltd. - Research Center

524804 AUROPHARMA Group (A) BSE data
Back to Company

Results

Statement

More

Half Yearly results in brief
(Rs crore)
Sep ' 23 Sep ' 22 Mar ' 22 Sep ' 21 Sep ' 20

Sales

5,059.58 5,812.58 5,510.22 5,776.93 7,944.04

Operating profit

967.56 538.16 722.88 750.54 2,171.97

Interest

68.28 27.05 8.45 8.50 16.85

Gross profit

1,061.24 605.68 1,259.09 868.36 2,329.32

EPS (Rs)

12.83 4.89 17.78 7.04 25.88
Half yearly  results in details
Sep ' 23 Sep ' 22 Mar ' 22 Sep ' 21 Sep ' 20

Other income

161.96 94.57 544.66 126.32 174.20

Stock adjustment

-43.37 -81.17 28.86 16.65 -19.35

Raw material

2,893.59 3,201.56 2,838.27 2,945.66 3,624.63

Power and fuel

- - - - -

Employee expenses

483.57 816.81 779.99 820.05 851.31

Excise

- - - - -

Admin and selling expenses

- - - - -

Research and development expenses

- - - - -

Expenses capitalised

- - - - -

Other expenses

758.23 1,337.22 1,140.22 1,244.03 1,315.48

Provisions made

- - - - -

Depreciation

125.42 211.85 202.42 212.83 239.93

Taxation

238.17 107.04 -60.01 242.78 573.17

Net profit / loss

751.69 286.79 1,041.97 412.75 1,516.22

Extra ordinary item

54.04 - -74.71 - -

Prior year adjustments

- - - - -

Equity capital

58.59 58.59 58.59 58.59 58.59

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

- - - - -

Agg.of non promotoholding (%)

- - - - -

OPM (%)

19.12 9.26 13.12 12.99 27.34

GPM (%)

20.32 10.25 20.79 14.71 28.69

NPM (%)

14.40 4.85 17.21 6.99 18.68
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com